SAN RAMON, Calif.–(BUSINESS WIRE)–BioVentrix, Inc., developer of the first hybrid transcatheter device for left ventricular remodeling after a heart attack, today announced that the Company has resumed cases in the pivotal ALIVE Trial studying Less Invasive Ventricular Enhancement, or LIVE™ Therapy, using the Revivent TC™ Transcatheter Ventricular Enhancement System. The […]
Other News
Miracor Medical Raises 24M€
Funds will be used for clinical studies and initiation of commercialization AWANS, Belgium–(BUSINESS WIRE)–Miracor Medical SA (Miracor Medical) has announced the closing of a 24M€ Series-E round of financing. The round was led by a new corporate strategic investor joined by co-investor Yonghua. Current investors Earlybird, Noshaq, Quest for Growth, […]
Acarix two largest shareholders transfer subscription rights free of charge – extends the subscription period
Press release Malmö, September 2, 2020 Acarix two largest shareholders transfer subscription rights free of charge –extends the subscription period The Extraordinary General Meeting of Acarix AB (“Acarix” or the “Company”) resolved on 11 August 2020, subsequent to the board of directors resolution on 15 July 2020, to approve […]
Amarin Supports Latest Clinical Research Evaluating VASCEPA® (Icosapent Ethyl) in Patients with Persistent Cardiovascular Risk Presented at ESC Congress 2020, the Annual Meeting of the European Society of Cardiology
VASCEPA is the first and only agent studied on top of statin therapy reported to exhibit coronary plaque regression in hypertriglyceridemic patients VASCEPA in REDUCE-IT® cardiovascular outcomes study achieved statistical significance for primary and secondary endpoints at predefined blinded first and second interim analyses that persisted at final analyses VASCEPA […]
Over Two Million Americans with Undiagnosed Atrial Fibrillation May Be Walking Time Bombs
DALLAS, Sept. 2, 2020 /PRNewswire/ — More than a decade ago, afib was a little-known condition. After creating Atrial Fibrillation Awareness Month, patient advocacy organization StopAfib.org worked with medical society partners to get the U.S. Senate to designate September as National Atrial Fibrillation (Afib) Awareness Month, which they did, in 2009. “That’s why […]
Baylis Medical Announces First Clinical Use of the All-in-One VersaCross® Steerable Solution
TORONTO, Sept. 1, 2020 /PRNewswire/ – Baylis Medical announced today the first clinical use of the VersaCross Steerable Access Solution, performed at the University of California, San Francisco (UCSF). The newest addition to the VersaCross Transseptal Platform combines the VersaCross RF wire with a steerable sheath, making it the ultimate, all-in-one solution to enable […]
Cardiac Dimensions Announces Australian Therapeutic Goods Administration’s Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation
KIRKLAND, Wash., Sept. 2, 2020 /PRNewswire/ — Cardiac Dimensions®, a leader in the development of innovative, minimally invasive treatments for functional mitral regurgitation (FMR) in patients with heart failure, today announced the Therapeutic Goods Administration (TGA) has approved its Carillon Mitral Contour System®. The Carillon System is a right heart transcatheter mitral valve […]
Concept Medical announces enrolment of index patient in the crucial Transform -1 RCT using MagicTouch sirolimus coated balloon for small coronary vessels
COTIGNOLA, Italy, Sept. 2, 2020 /PRNewswire/ — Concept Medical Inc., focused on vascular intervention drug delivery devices, has announced the enrolment of the first patient in the TRANSFORM-1 RCT (TReAtmeNt of Small coronary vessels: Randomized controlled trial FOR MagicTouch sirolimus coated balloon). TRANSFORM-1 is a prospective, randomized, multi-center, European study focusing on coronary artery lesions in small vessels with a […]
Artio Medical Appoints Paul Muller as Chief Technology Officer and General Manager
Proven leader with over 30 years of success developing novel medical devices PRAIRIE VILLAGE, Kan., Sept. 1, 2020 /PRNewswire/ — Artio Medical, Inc. (Artio), a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced it has named Paul Muller to serve as Chief Technology Officer (CTO) and General […]
Cardiologs Partners with MicroPort CRM to Distribute its AI-based Cardiac Diagnostics Solution in France
The ECG Holter agreement marks the launch of Cardiologs’ AI-based cloud technology business operations in Europe to detect cardiac rhythm disorders BOSTON, Sept. 1, 2020 /PRNewswire/ — Cardiologs, a global leader in artificial intelligence (AI) cardiology diagnostics, today announced an exclusive distribution agreement in France with MicroPort CRM, for the reselling of its cloud analysis solution […]



